Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging Neuroimmune Response to LPS
NCT04233593Phase 1Completed
- Sponsor
- Yale University
- Start
- Mar 2014
- Primary completion
- Aug 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lipopolysaccharide endotoxin, sponsored by Yale University. Primary endpoint: Baseline TSPO Availability. Started Mar 2014; status: completed.
02
Drugs
lipopolysaccharide endotoxin
Beyond the preview
Go deeper on NCT04233593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233593.